These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23160258)

  • 1. Rebuttal: PTH--a particularly tricky hormone: why measure it at all in kidney patients?
    Sprague SM; Moe SM
    Clin J Am Soc Nephrol; 2013 Feb; 8(2):321. PubMed ID: 23160258
    [No Abstract]   [Full Text] [Related]  

  • 2. PTH--a particularly tricky hormone: why measure it at all in kidney patients?
    Garrett G; Sardiwal S; Lamb EJ; Goldsmith DJ
    Clin J Am Soc Nephrol; 2013 Feb; 8(2):299-312. PubMed ID: 22403273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebuttal: the case for routine parathyroid hormone monitoring.
    Goldsmith DJ
    Clin J Am Soc Nephrol; 2013 Feb; 8(2):319-20. PubMed ID: 23160263
    [No Abstract]   [Full Text] [Related]  

  • 4. Parathyroid hormone measurement in CKD.
    Souberbielle JC; Roth H; Fouque DP
    Kidney Int; 2010 Jan; 77(2):93-100. PubMed ID: 19812537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical value of two methods to measure parathyroid hormone in chronic renal insufficiency, considering vitamin D metabolism].
    Kovács L; Virágh E; Balogh D; Kálmán B; Lőcsei Z; Toldy E
    Orv Hetil; 2013 Dec; 154(51):2025-36. PubMed ID: 24334134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The case for routine parathyroid hormone monitoring.
    Sprague SM; Moe SM
    Clin J Am Soc Nephrol; 2013 Feb; 8(2):313-8. PubMed ID: 23037984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Second- and Third-Generation Parathyroid Hormone Test Results in Patients with Chronic Kidney Disease.
    Wójtowicz M; Piechota W; Wańkowicz Z; Smoszna J; Niemczyk S
    Med Sci Monit; 2020 Dec; 26():e928301. PubMed ID: 33361742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why Current PTH Assays Mislead Clinical Decision Making in Patients with Secondary Hyperparathyroidism.
    Hocher B; Yin L
    Nephron; 2017; 136(2):137-142. PubMed ID: 28183082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone measurement in chronic kidney disease: Impact of inter-method variability on mineral bone disease assessment.
    White CA; Sarabia S; Collier CP; McCudden C; Holden RM
    Clin Biochem; 2021 Aug; 94():62-66. PubMed ID: 33895125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease.
    Carrillo-López N; Panizo S; Alonso-Montes C; Martínez-Arias L; Avello N; Sosa P; Dusso AS; Cannata-Andía JB; Naves-Díaz M
    Nephrol Dial Transplant; 2019 Jun; 34(6):934-941. PubMed ID: 30189026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Plasma Intact Parathyroid Hormone Levels and the Prevalence of Atrial Fibrillation in Patients With Chronic Kidney Disease　- The Fukuoka Kidney Disease Registry Study.
    Arase H; Yamada S; Tanaka S; Tokumoto M; Tsuruya K; Nakano T; Kitazono T
    Circ J; 2020 Jun; 84(7):1105-1111. PubMed ID: 32507801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alkaline phosphatase: better than PTH as a marker of cardiovascular and bone disease?
    Lau WL; Kalantar-Zadeh K; Kovesdy CP; Mehrotra R
    Hemodial Int; 2014 Oct; 18(4):720-4. PubMed ID: 25597344
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.
    Taal MW; Thurston V; McIntyre NJ; Fluck RJ; McIntyre CW
    Kidney Int; 2014 Aug; 86(2):407-13. PubMed ID: 24429404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease.
    Geng S; Kuang Z; Peissig PL; Page D; Maursetter L; Hansen KE
    Osteoporos Int; 2019 Oct; 30(10):2019-2025. PubMed ID: 31190122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Need for better PTH assays for clinical research and patient treatment.
    Hocher B; Zeng S
    Clin Chem Lab Med; 2018 Jan; 56(2):183-185. PubMed ID: 28809750
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum level vitamin D and parathyroid hormone, and mortality, with or without chronic kidney disease.
    Kyun Choi C; Kweon SS; Lee YH; Nam HS; Park KS; Ryu SY; Choi SW; Kim SA; Shin MH
    J Bone Miner Metab; 2019 Sep; 37(5):825-834. PubMed ID: 30535953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid Hormone, Fibroblast Growth Factor 23, and Parameters of Phosphate Reabsorption.
    Phelps KR; Mason DL
    Am J Nephrol; 2018; 47(5):343-351. PubMed ID: 29779023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of chronic kidney disease on intraoperative parathyroid hormone: A linear mixed model analysis.
    Graves CE; Hwang R; McManus CM; Lee JA; Kuo JH
    Surgery; 2021 May; 169(5):1152-1157. PubMed ID: 33423798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of concurrent chronic kidney disease on intraoperative parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism.
    Sunkara B; Cohen MS; Miller BS; Gauger PG; Hughes DT
    Surgery; 2018 Jan; 163(1):42-47. PubMed ID: 29128188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum parathyroid hormone concentrations measured by chemiluminescence and electrochemiluminescence methods — are the results comparable in haemodialysis patients with chronic kidney disease?
    Kuczera P; Maszczyk A; Machura E; Kurzak E; Adamczak M; Więcek A
    Endokrynol Pol; 2015; 66(3):219-23. PubMed ID: 26136130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.